Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?

AIM: We report molecular subtype impact on 1325 early breast cancer (BCa) patients treated with whole breast hypofractionated (WBH) adjuvant forward-planned intensity modulated radiotherapy (F-IMRT) without boost. METHODS AND MATERIALS: From 02/2009-05/2017 1325 patients with pTis-pT3, pNx-N1aM0 BCa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fodor, Andrei, Brombin, Chiara, Mangili, Paola, Borroni, Fulvio, Pasetti, Marcella, Tummineri, Roberta, Zerbetto, Flavia, Longobardi, Barbara, Perna, Lucia, Dell’Oca, Italo, Deantoni, Chiara L., Deli, Aniko M., Chiara, Anna, Broggi, Sara, Castriconi, Roberta, Esposito, Pier Giorgio, Slim, Najla, Passoni, Paolo, Baroni, Simone, Villa, Stefano L., Rancoita, Paola M.V., Fiorino, Claudio, Del Vecchio, Antonella, Bianchini, Giampaolo, Gentilini, Oreste D., Di Serio, Mariaclelia S., Di Muzio, N.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736720/
https://www.ncbi.nlm.nih.gov/pubmed/33326894
http://dx.doi.org/10.1016/j.breast.2020.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736720/
https://www.ncbi.nlm.nih.gov/pubmed/33326894
http://dx.doi.org/10.1016/j.breast.2020.12.004

Ejemplares similares